Jubilant Receives EIR From USFDA For Its Solid Dosage Facility At Salisbury, Maryland USA

Jubilant Life Sciences Limited, an integrated global Pharmaceutical and Life Sciences Company, has announced that Jubilant Pharma Limited, a material wholly owned subsidiary of the Company, through one of its wholly owned subsidiaries, has received the Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) status from the USFDA for its Solid Dosage Facility at Salisbury, Maryland USA in respect of the inspection conducted by the regulatory agency from February 24, 2020 to February 28, 2020. With the receipt of the EIR, the inspection stands successfully closed.

Shares of JUBILANT LIFE SCIENCES LIMITED was last trading in BSE at Rs.248.85 as compared to the previous close of Rs. 234.55. The total number of shares traded during the day was 11520 in over 1870 trades.

The stock hit an intraday high of Rs. 255 and intraday low of 235. The net turnover during the day was Rs. 2853278.

Equity Bulls

Share this:

Related Post

Stay Updated on Medical Equipment and Devices industry.
Receive our Daily Newsletter.